Combination therapy with chitosan/siRNA nanoplexes targeting PDGF‐D and PDGFR‐β reveals anticancer effect in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination therapy with chitosan/siRNA nanoplexes targeting PDGF‐D and PDGFR‐β reveals anticancer effect in breast cancer

Published:2022-12-11 Issue:2 Volume:25 Page:
ISSN:1099-498X
Container-title:The Journal of Gene Medicine
language:en
Short-container-title:The Journal of Gene Medicine

Author:

Şalva Emine¹^ORCID,Özbaş Suna²,Alan Saadet³,Özkan Naziye⁴,Ekentok‐Atıcı Ceyda²^ORCID,Kabasakal Levent⁵,Akbuğa Jülide⁶

Affiliation:

1. Department of Pharmaceutical Biotechnology İnönü University, Faculty of Pharmacy Malatya Turkey

2. Department of Pharmaceutical Biotechnology Marmara University, Faculty of Pharmacy İstanbul Turkey

3. Department of Medical Pathology İnönü University, Faculty of Medicine Malatya Turkey

4. Department of Pathology Marmara University, Vocational Health School İstanbul Turkey

5. Department of Pharmacology Marmara University, Faculty of Pharmacy İstanbul Turkey

6. Department of Pharmaceutical Technology Medipol University, Faculty of Pharmacy İstanbul Turkey

Publisher

Wiley

Subject

Genetics (clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgm.3465

Reference44 articles.

1. Angiogenesis in Breast Cancer Progression, Diagnosis, and Treatment

2. PDGF-D Signaling: A Novel Target in Cancer Therapy

3. Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression

4. Expression of endothelial PDGF receptors α and β in breast cancer: Up-regulation of endothelial PDGF receptor β

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments;Pharmaceutics;2024-01-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3